Akari Therapeutics Plc - AKTX

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2026 · Compare: Q2 2026
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
MMCAP International Inc. SPC History No change 100,000 1,024 0.09% 0.09% 1 0 0.0% Q2 2026 Aug 14, 2026
Cresset Asset Management, LLC History No change 20,561 210 0.0% 0.0% 2 0 0.0% Q2 2026 Aug 14, 2026
JANE STREET GROUP, LLC History No change 15,463 158 0.0% 0.0% 3 0 0.0% Q2 2026 Aug 14, 2026
HRT FINANCIAL LP History No change 13,745 140 0.0% 0.0% 4 0 0.0% Q2 2026 Aug 14, 2026
CITADEL ADVISORS LLC History No change 10,000 102 0.0% 0.0% 5 0 0.0% Q2 2026 Sep 02, 2026
GAMMA Investing LLC History New 2,411 22 0.0% — 6 +2,411 New Q3 2026 Oct 08, 2026
IFP Advisors, Inc History No change 181 1 0.0% 0.0% 7 0 0.0% Q2 2026 Jul 20, 2026
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO History No change 7 0 — — — 0 0.0% Q2 2026 Aug 12, 2026
Truvestments Capital LLC History No change 1 0 — — — 0 0.0% Q2 2026 Aug 12, 2026
SBI Securities Co., Ltd. History No change 14 0 — — — 0 0.0% Q2 2026 Jul 22, 2026
Caitong International Asset Management Co., Ltd History No change 8 0 — — — 0 0.0% Q2 2026 Aug 04, 2026